Interventions that block signaling via RAGE (Soro-Paavonen et al., 2008) or the AT1R (Candido et al., 2004) have proved effective in reducing plaque formation in mouse models with diabetes. This evidence concerns the gene AGTR1 and diabetes mellitus.